Voriconazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Voriconazole and local guidelines before prescribing.
Mechanism
Triazole inhibiting fungal ergosterol synthesis.
Uses
Invasive aspergillosis (first line), candidaemia, resistant fungal infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Visual disturbance, hallucinations, raised LFT, photosensitivity, QT prolongation.
Interactions
CYP2C19, 2C9 and 3A4 inhibitor: warfarin, ciclosporin, tacrolimus, statins; rifampicin contraindicated.
Contraindications and cautions
Severe liver disease, QT prolongation
Monitoring
Trough level, LFT, visual symptoms
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in cirrhosis; IV vehicle accumulates if CrCl below 50
Overdose and reversal
Supportive
Special advice
Therapeutic drug monitoring; sun protection; liver function monthly.
More from the textbook: uses, cautions and other points
- Antifungals - voriconazole (aspergillosis - visual disturbance, photosensitivity, skin cancer risk, many interactions); itraconazole (ABPA, chronic aspergillosis).
Respiratory: Anatomy, Physiology and Pharmacology - Voriconazole or isavuconazole (monitor levels and interactions). High mortality.
Respiratory: Infections - Itraconazole / voriconazole | Chronic pulmonary aspergillosis (and ABPA); voriconazole for invasive aspergillosis. Level monitoring; many interactions; voriconazole causes visual disturbance and photosensitivity.
Respiratory: Infections - Voriconazole | Invasive aspergillosis (first-line) | Level monitoring; visual disturbance , hallucinations, photosensitivity and skin cancer , liver toxicity, periostitis, QT; many interactions
ID: How Infection Happens - Voriconazole , posaconazole | Trough after about 5–7 days | Wide variation in levels (genetics, interactions); toxicity and failure
ID: How Infection Happens - Long courses of oral antifungals (itraconazole or voriconazole) for at least 6 months.
Respiratory: Infections - Photosensitising drugs - doxycycline, thiazides, amiodarone, NSAIDs, retinoids, voriconazole (SCC risk), St John's wort.
Dermatology: Skin lesions and skin cancer - Risk factors - cumulative sun exposure (outdoor workers), older age, fair skin, actinic keratoses , immunosuppression (organ transplant recipients - up to 100 times higher risk), chronic wounds and scars ( Marjolin ulcer ), radiotherapy, HPV (genital and periungual SCC), lichen sclerosus and lichen planus (genital and oral), smoking …
Dermatology: Skin lesions and skin cancer
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Infections (3 mentions)
- Dermatology: Skin lesions and skin cancer (3 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- ID: How Infection Happens (4 mentions)
- ID: Viral, fungal and parasitic infections (8 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (2 mentions)
- Integrated respiratory chapter (3 mentions)
- Microbiology: Fungi, parasites and travel-related infection (5 mentions)